Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Circulating Cell-Free DNA in Classical Hodgkin Lymphoma in Children, Adolescents and Young Adults. Results from the Holy Study, a French Ancillary Study of Euronet PHL-C2 Protocol

Blood (2024) 144 (Supplement 1): 1592.

https://doi.org/10.1182/blood-2024-194387

Published: 2024

Journal Articles

APR-246 Overcomes Resistance to Asparaginase in Lymphoid Malignancies By Targeting Metabolic Cell Vulnerabilities

Amira Marouf, Raphaël Liévin, Mathilde Bonnet des Claustres, Matthias Titeux, Mathieu Simonin, Manon Vavasseur, Amandine Mainreck, Mehdi Latiri, Aurore Touzart, Marie Bouillié, Olivier Pellé, Nicolas Gaidot, Mathieu Rocquet, Didier Bouscary, Arnaud Jaccard, Vahid Asnafi, Olivier Hermine, Guillaume P Andrieu, Lucile Couronné

Blood (2024) 144 (Supplement 1): 2793.

https://doi.org/10.1182/blood-2024-207423

Published: 2024

Journal Articles

R-CVP in Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children

Thi An VU, Laura Olivier, Mathieu Simonin, Sabah Boudjemaa, Bénédicte Jonca, Charlotte Rigaud, Nathalie Garnier, Ludovic Mansuy, Catherine Curtillet, Pauline Treguier, Florent Neumann, Sebastien Heritier, Marie-Emilie Dourthe, Judith Landman-Parker

Blood (2024) 144 (Supplement 1): 6349.

https://doi.org/10.1182/blood-2024-209703

Published: 2024

Journal Articles

NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients

Blood (2024) 144 (15): 1570–1580.

https://doi.org/10.1182/blood.2023023754

Published: 2024

Includes: Supplemental data

Journal Articles

Genomic imbalance analysis provides new insight into prognostic factors in adult and pediatric T-ALL

Blood (2024) 144 (9): 988–1000.

https://doi.org/10.1182/blood.2023022154

Published: 2024

Includes: Supplemental data

Journal Articles

NGS-Based Stratification Refines the Risk Stratification in T-ALL and Identifies a Very High-Risk Subgroup of Patients

Blood (2023) 142 (Supplement 1): 844.

https://doi.org/10.1182/blood-2023-179298

Published: 2023

Journal Articles

Chromothripsis and Genomic Complexity As Pejorative Prognostic Markers in Pediatric and Adult T-ALL

Blood (2023) 142 (Supplement 1): 2980.

https://doi.org/10.1182/blood-2023-185831

Published: 2023

Journal Articles

Oncogenetic-Driven Targeted Therapy for Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia : A French ALL-Target Observatory Report

Blood (2023) 142 (Supplement 1): 518.

https://doi.org/10.1182/blood-2023-179192

Published: 2023

Journal Articles

IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibition

Lucien Courtois, Aurélie Cabannes-Hamy, Rathana Kim, Marine Delecourt, Antoine Pinton, Guillaume Charbonnier, Mélanie Feroul, Charlotte Smith, Giulia Tueur, Cécile Pivert, Estelle Balducci, Mathieu Simonin, Laure Hélène Angel, Salvatore Spicuglia, Nicolas Boissel, Guillaume P. Andrieu, Vahid Asnafi, Philippe Rousselot, Ludovic Lhermitte

Blood (2023) 142 (2): 158–171.

https://doi.org/10.1182/blood.2022017948

Published: 2023

Includes: Supplemental data

Journal Articles

Prognostic value and oncogenic landscape of TP53 alterations in adult and pediatric T-ALL

Blood (2023) 141 (11): 1353–1358.

https://doi.org/10.1182/blood.2022017755

Published: 2023

Includes: Supplemental data

Journal Articles

Metabolic Plasticity Reveals a Targetable Vulnerability in Leukemia

Guillaume P Andrieu, Mathieu Simonin, Aurélie Cabannes-Hamy, Etienne Lengline, Ambroise Marçais, Marie Emilie Dourthe, Nicolas Boissel, Hervé Dombret, Philippe Rousselot, Olivier Hermine, Vahid Asnafi

Blood (2022) 140 (Supplement 1): 5893–5895.

https://doi.org/10.1182/blood-2022-168665

Published: 2022

Journal Articles

PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALL

Guillaume P. Andrieu, Milena Kohn, Mathieu Simonin, Charlotte L. Smith, Agata Cieslak, Marie-Émilie Dourthe, Guillaume Charbonnier, Carlos Graux, Françoise Huguet, Véronique Lhéritier, Hervé Dombret, Salvatore Spicuglia, Philippe Rousselot, Nicolas Boissel, Vahid Asnafi

Blood (2021) 138 (19): 1855–1869.

https://doi.org/10.1182/blood.2020010081

Published: 2021

Includes: Supplemental data

Journal Articles

IKZF1 alterations predict poor prognosis in adult and pediatric T-ALL

Mathieu Simonin, Ludovic Lhermitte, Marie-Emilie Dourthe, Etienne Lengliné, Carlos Graux, Nathalie Grardel, Jean-Michel Cayuela, Isabelle Arnoux, Virginie Gandemer, Norbert Ifrah, Hervé Dombret, André Baruchel, Elizabeth Macintyre, Arnaud Petit, Nicolas Boissel, Vahid Asnafi

Blood (2021) 137 (12): 1690–1694.

https://doi.org/10.1182/blood.2020007959

Published: 2021

Includes: Supplemental data

Journal Articles

Caution encouraged in next-generation sequencing immunogenetic analyses in acute lymphoblastic leukemia

Chrystelle Abdo, Florian Thonier, Mathieu Simonin, Sophie Kaltenbach, Julie Valduga, Arnaud Petit, Monika Brüggemann, Elizabeth Macintyre

Blood (2020) 136 (9): 1105–1107.

https://doi.org/10.1182/blood.2020005613

Published: 2020

NARROW

Circulating Cell-Free DNA in Classical Hodgkin Lymphoma in Children, Adolescents and Young Adults. Results from the Holy Study, a French Ancillary Study of Euronet PHL-C2 Protocol

APR-246 Overcomes Resistance to Asparaginase in Lymphoid Malignancies By Targeting Metabolic Cell Vulnerabilities

R-CVP in Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children

NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients

Genomic imbalance analysis provides new insight into prognostic factors in adult and pediatric T-ALL

NGS-Based Stratification Refines the Risk Stratification in T-ALL and Identifies a Very High-Risk Subgroup of Patients

Chromothripsis and Genomic Complexity As Pejorative Prognostic Markers in Pediatric and Adult T-ALL

Oncogenetic-Driven Targeted Therapy for Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia : A French ALL-Target Observatory Report

IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibition

Prognostic value and oncogenic landscape of TP53 alterations in adult and pediatric T-ALL

Metabolic Plasticity Reveals a Targetable Vulnerability in Leukemia

PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALL

IKZF1 alterations predict poor prognosis in adult and pediatric T-ALL

Caution encouraged in next-generation sequencing immunogenetic analyses in acute lymphoblastic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only